Skip to main content
Menu
US

GSP Neonatal Creatine Kinase -MM kit

The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Feature Specification
Application Newborn Screening

The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Product Variant
Unit Size: 1 kit
Part #:
3311-0010
Request More Information

Overview

This assay measures muscle specific creatine kinase in dried blood spots, helping to detect newborns affected by Duchenne Muscular Dystrophy.

Revvity's GSP® Neonatal Creatine Kinase –MM kit is an immunoassay for measuring CK-MM in dried blood spot samples of newborn babies. As the assay measures the muscle specific isoform, it enables the screening process to find the babies affected by DMD. The kit is available on Revvity's GSP® instrument, a fully automated, high throughput biochemical analyzer.

Benefits of the assay:

  • The first CE-IVD kit for Duchenne Muscular Dystrophy screening
  • Fully automated – no reagent preparation
  • High sensitivity and specificity – good separation between affected and unaffected cases
  • Wide measuring range enabling numerical result also from most of the non-affected cases
  • Kit includes reagents, QC material and specific QC certificates
  • Robust and reliable DELFIA® platform performance

Specifications

Application
Newborn Screening
Brand
GSP®
Detection Modality
Enzymatic
Disorders
Duchenne Muscular Dystrophy
Instrument Compatibility
GSP
Quantity
500 tests
Sample Type
Dried blood spots
Technology
Enzymatic
Unit Size
1 kit

Resources

Are you looking for resources, click on the resource type to explore further.

Scroll Icon